Acute myeloid leukemia in the next-generation sequencing era: Real-world data from an Austrian tertiary cancer care center
S Wurm, M Waltersdorfer, S Loindl, JM Moritz… - Wiener klinische …, 2024 - Springer
Background Next-generation sequencing (NGS) has recently entered routine acute myeloid
leukemia (AML) diagnostics. It is paramount for AML risk stratification and identification of …
leukemia (AML) diagnostics. It is paramount for AML risk stratification and identification of …
The Promising Diagnostic use of NGS in Pediatric B-ALL: Profiling of B-other ALL.
J Garcia-Heras - Journal of the Association of Genetic …, 2023 - search.ebscohost.com
A recent landmark study reported the value of next-generation sequencing (NGS) to uncover
pathogenic abnormalities of clinical significance in patients with pediatric B-ALL enrolled in …
pathogenic abnormalities of clinical significance in patients with pediatric B-ALL enrolled in …
The Confirmatory Diagnostic Value of Whole Genome Sequencing (WGS) as a Standalone Test for Childhood B-cell ALL: The Results of a NOPHO Trials Cohort.
J Garcia-Heras - Journal of the Association of Genetic …, 2023 - search.ebscohost.com
The latest study with whole genome sequencing (WGS) in pediatric B-ALL validated its use
as a standalone test to detect underlying clinically significant genetic abnormalities …
as a standalone test to detect underlying clinically significant genetic abnormalities …